Global Robotics in Drug Discovery Market, By Type (Traditional Robots, Collaborative Robots), End User (Biopharmaceutical and Pharmaceutical Companies, Research Laboratories), Component Type (Hardware, Software, Service), Robots Type (Autonomous, Semi- Autonomous), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights of Robotics in Drug Discovery Market
Data Bridge Market Research analyses that the robotics in drug discovery market will exhibit a CAGR of around 12.40% for the forecast period of 2022-2029. Rising demand for automation in drug discovery, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced IT healthcare technologies, rising deployment of pharmaceutical robots for a wide range of applications and rising expenditure for the development of healthcare infrastructure especially in the developing economies are the major factors attributable to the growth of robotics in drug discovery market.
Robotics is being increasingly used in drug discovery purposes. Robotics assists in the automation processes. Robotics is based on advanced technologies such as artificial intelligence and machine learning.
Upsurge in the public-private funding for target research activities coupled with increased awareness about the advantages provided by the robotic systems in pharmaceutical manufacturing is one of the major factors fostering the growth of the market. Rising technological advancements and development in the field of robotics is another market growth determinant. Ever- rising technological advancement and innovation of new medical devices and instruments, increased number of product launches, growing support of the government for research activities, surging awareness about the benefits of robotics in the field of medical science and increased government funding and untapped potential of the emerging markets will further generate lucrative market growth opportunities.
However, high initial investments associated with the deployment of technology and lack of skilled medical professionals will derail the market growth rate. Also, lack of awareness in the underdeveloped and backward economies and high expenditure required for research and development activities will further pose challenges for the market.
This robotics in drug discovery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on robotics in drug discovery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Robotics in Drug Discovery Market Scope and Market Size
The robotics in drug discovery market is segmented on the basis of type, end users, component type and robots type. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on type, the robotics in drug discovery market is segmented into traditional robots and collaborative robots.
- The global robotics in drug discovery market has also been segmented based on the end users into biopharmaceutical and pharmaceutical companies and research laboratories.
- The component type segment of the robotics in drug discovery market is segmented into hardware, service and software.
- The robot type segment of robotics in drug discovery market is divided into autonomous and semi- autonomous.
Robotics in Drug Discovery Market Country Level Analysis
The robotics in drug discovery market is analysed and market size insights and trends are provided by country, type, end users, component type and robots type as referenced above.
The countries covered in the robotics in drug discovery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the robotics in drug discovery market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increase in the expenditure for research and development proficiencies and presence of major players in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the increasing government expenditure on healthcare sector and increasing adoption of robotic technology by the healthcare industry.
The country section of the robotics in drug discovery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The robotics in drug discovery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for robotics in drug discovery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the robotics in drug discovery market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Robotics in Drug Discovery Market Share Analysis
The robotics in drug discovery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to robotics in drug discovery market.
Some of the major players operating in the robotics in drug discovery market report are Kawasaki Heavy Industries, Ltd., KUKA AG, YASKAWA ELECTRIC CORPORATION, Mitsubishi Electric Corporation, DENSO WAVE INCORPORATED., AstraZeneca, FANUC Corporation, Universal Robots, Nachi Robotic Systems, Inc., Rethink Robotics, Robert Bosch GmbH, Kawasaki Heavy Industries, Ltd, ABB, Stäubli International AG, YASKAWA ELECTRIC CORPORATION, Comau S.p.A., Teradyne Inc., Automatica Kassow Robots, Vecna, Robotiq Inc., and OMRON Corporation among others.